Quantcast

Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr Instagram
POZ Personals
Sign In / Join
Username:
Password:
Welcome, Guest. Please login or register.
December 18, 2014, 03:28:35 PM

Login with username, password and session length


Members
Stats
  • Total Posts: 649774
  • Total Topics: 49592
  • Online Today: 284
  • Online Ever: 585
  • (January 07, 2014, 02:31:47 PM)
Users Online
Users: 5
Guests: 133
Total: 138

Welcome


Welcome to the POZ/AIDSmeds Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Am I Infected?” posting guidelines. Click here for posting guidelines pertaining to all other POZ/AIDSmeds community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Vaccine Trial Starts in Los Angeles  (Read 1297 times)

0 Members and 1 Guest are viewing this topic.

Offline marius68

  • Member
  • Posts: 27
Vaccine Trial Starts in Los Angeles
« on: October 31, 2009, 10:05:51 AM »
A new therapeutic vaccine is being tested! That's good news. I have great hopes that any of the vaccines being tested now, either alone or in combination with other vaccine(s), will provide the means to control the virus.

http://www.hivplusmag.com/NewsStory.asp?id=21566&sd=10/30/2009-11/01/2009

AIDS Research Alliance of America, in collaboration with the University of California, Los Angeles, has launched the latest HIV vaccine study in Los Angeles today. As part of the National Institutes of Health-funded HIV Vaccine Trials Network, ARA is one of 14 sites throughout the United States to begin testing a new prime-boost HIV vaccine that may provide valuable insight into how to better control HIV infection.

The NIH-funded HVTN 505 is a Phase 2, proof-of-concept study that employs a prime-boost strategy of two investigational vaccines developed by scientists at NIH's Vaccine Research Center. Study volunteers will be vaccinated with either (a) a recombinant DNA-based vaccine (the primer vaccine) over the course of eight weeks followed by a single immunization with a recombinant boosting vaccine or (b) placebos at the same intervals.

The primary study objective is to see if the prime boost vaccine can significantly reduce the amount of virus in individuals who become infected with HIV. This is important because viral load is a marker of potential vaccine effect on disease progression, and therefore, a signal of potential vaccine efficacy. An HIV vaccine that lowers viral load may also delay the onset of illness, even if it doesn't prevent HIV infection, and may also reduce transmission of the virus to others.

Neither of the two vaccines contains HIV, and neither vaccine can infect study participants with the virus. Both vaccines have been found safe when tested in hundreds of people in earlier clinical trials.

Offline Inchlingblue

  • Member
  • Posts: 3,119
  • Chad Ochocinco PETA Ad
Re: Vaccine Trial Starts in Los Angeles
« Reply #1 on: October 31, 2009, 11:34:06 AM »
Here is more information about this study:

http://forums.poz.com/index.php?topic=28993.0

 


Terms of Membership for these forums
 

© 2014 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.